scholarly article | Q13442814 |
P2093 | author name string | Sang Chul Park | |
Sung Young Kim | |||
P2860 | cites work | Serum bilirubin and risk of colorectal cancer | Q79171875 |
Old biliverdin reductase: links to insulin resistance and may be a novel therapeutic target | Q81036494 | ||
Bilirubin and amyotrophic lateral sclerosis | Q81396364 | ||
Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes | Q82295763 | ||
The Bilirubin-Increasing Drug Atazanavir Improves Endothelial Function in Patients With Type 2 Diabetes Mellitus | Q82507853 | ||
Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes | Q82901620 | ||
Low serum bilirubin concentration in haemodialysis patients with Type 2 diabetes | Q83141039 | ||
High serum bilirubin is associated with the reduced risk of diabetes mellitus and diabetic nephropathy | Q84285095 | ||
Free radicals and antioxidants in normal physiological functions and human disease | Q21710698 | ||
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a | Q24324559 | ||
Biliverdin reductase: a major physiologic cytoprotectant | Q24541497 | ||
A biomarker that identifies senescent human cells in culture and in aging skin in vivo | Q24562644 | ||
Bilirubin and glutathione have complementary antioxidant and cytoprotective roles | Q24649034 | ||
THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS | Q28202269 | ||
Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin | Q28235160 | ||
Biliverdin reductase, a novel regulator for induction of activating transcription factor-2 and heme oxygenase-1 | Q28247218 | ||
Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle | Q28264545 | ||
Cellular senescence: when bad things happen to good cells | Q29615561 | ||
Oxidative stress, caloric restriction, and aging | Q29618229 | ||
Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein | Q31120123 | ||
Reactivity and mutagenicity of endogenous DNA oxopropenylating agents: base propenals, malondialdehyde, and N(epsilon)-oxopropenyllysine. | Q31729641 | ||
Nuclear localization of biliverdin reductase in the rat kidney: response to nephrotoxins that induce heme oxygenase-1. | Q31963580 | ||
Lipids and lipidomics in brain injury and diseases | Q33247769 | ||
Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate | Q33710597 | ||
Human biliverdin reductase: a member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity | Q33771641 | ||
Chemistry and biology of DNA damage by malondialdehyde. | Q33811672 | ||
Baseline diene conjugation in LDL lipids: an indicator of circulating oxidized LDL. | Q33821043 | ||
High Total Bilirubin as a Protective Factor for Diabetes Mellitus: An Analysis of NHANES Data From 1999 - 2006 | Q33918067 | ||
Role of oxidative stress in cardiovascular diseases | Q33953686 | ||
Bilirubin as a Protective Factor for Rheumatoid Arthritis: An NHANES Study of 2003 - 2006 Data | Q34063518 | ||
Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels | Q34114552 | ||
Oxidative DNA damage and senescence of human diploid fibroblast cells. | Q34323707 | ||
Potential role of conjugated bilirubin and copper in the metabolism of lipid peroxides in bile | Q34367182 | ||
The coordinated increased expression of biliverdin reductase and heme oxygenase-2 promotes cardiomyocyte survival: a reductase-based peptide counters β-adrenergic receptor ligand-mediated cardiac dysfunction | Q34421837 | ||
Biliverdin reductase A in the prevention of cellular senescence against oxidative stress | Q34587100 | ||
Biliverdin reductase is a transporter of haem into the nucleus and is essential for regulation of HO-1 gene expression by haematin | Q34656126 | ||
Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress | Q34657995 | ||
Endogenous oxidative stress: relationship to aging, longevity and caloric restriction | Q34688072 | ||
Aging is associated with increased lipid peroxidation in human hearts, but not with mitochondrial respiratory chain enzyme defects | Q57631629 | ||
Effect of serum albumin and bilirubin on the risk of myocardial infarction (the Framingham Offspring Study) | Q57798862 | ||
Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study | Q57798919 | ||
Effects of light on low nocturnal bilirubin in winter depression: a preliminary report | Q59792464 | ||
Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension | Q61831037 | ||
Oxidative stress induces p21 expression in pancreatic islet cells: possible implication in beta-cell dysfunction | Q64381323 | ||
Serum bilirubin concentration in a Belgian population: the association with smoking status and type of cigarettes. | Q64891953 | ||
[Indicators of oxidative stress and the effect of antioxidant treatment in patients with primary Parkinson disease] | Q64911427 | ||
[The role of oxygen free radicals in the aging of the brain] | Q68533743 | ||
Antioxidant activities of bile pigments: biliverdin and bilirubin | Q68592261 | ||
Mechanism for depression of heart sarcolemmal Ca2+ pump by oxygen free radicals | Q69356582 | ||
Possible mechanism of unconjugated bilirubin toxicity on renal tissue | Q69904203 | ||
[Role of bilirubin as a natural antioxidant in regulating lipid peroxidation intensity in acute viral hepatitis] | Q70057588 | ||
Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins | Q71004674 | ||
Sex- and age-related differences in bilirubin concentrations in serum | Q71423972 | ||
Association of low serum concentration of bilirubin with increased risk of coronary artery disease | Q72722527 | ||
Serum albumin, bilirubin, and uric acid and the anatomic site-specific incidence of colon cancer | Q72880684 | ||
[HO (heme oxygenase)/CO (carbon monoxide) system] | Q73064208 | ||
Nitric oxide activates skeletal and cardiac ryanodine receptors | Q73122913 | ||
Neuroprotective action of bilirubin against oxidative stress in primary hippocampal cultures | Q73432693 | ||
Age-related changes in reactive oxygen species production in rat brain homogenates | Q73661245 | ||
A patient with exacerbation of idiopathic pulmonary fibrosis which was resolved probably due to the coexisting hyperbilirubinemia? | Q73791784 | ||
Serum bilirubin concentration in patients with amyotrophic lateral sclerosis | Q73898319 | ||
Free radical generation and oxidative stress with ageing and exercise: differential effects in the myocardium and liver | Q74198617 | ||
Heme oxygenase-2 acts to prevent neuronal death in brain cultures and following transient cerebral ischemia | Q74272605 | ||
Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species | Q74602438 | ||
Molecular analysis of H2O2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication | Q41045031 | ||
Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts | Q41053539 | ||
Antioxidant and cytotoxic effects of bilirubin on neonatal erythrocytes. | Q41615523 | ||
Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts | Q41725165 | ||
Multiple forms of biliverdin reductase: age-related change in pattern of expression in rat liver and brain | Q41979035 | ||
Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment | Q42170202 | ||
Molecular requirements for the mutagenicity of malondialdehyde and related acroleins. | Q42247881 | ||
Caloric restriction improves endothelial dysfunction during vascular aging: Effects on nitric oxide synthase isoforms and oxidative stress in rat aorta | Q42967913 | ||
The biliverdin-bilirubin antioxidant cycle of cellular protection: Missing a wheel? | Q43024048 | ||
Elevated malondialdehyde correlates with the extent of primary tumor and predicts poor prognosis of oropharyngeal cancer. | Q43257162 | ||
Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. | Q43638880 | ||
Mutagenicity of the malondialdehyde oligomerization products 2-(3'-oxo-1'-propenyl)-malondialdehyde and 2,4-dihydroxymethylene-3-(2,2-dimethoxyethyl)glutaraldehyde in Salmonella | Q43722174 | ||
Effect of bilirubin on lipid peroxidation, sphingomyelinase activity, and apoptosis induced by sphingosine and UV irradiation | Q43795596 | ||
Heme Oxygenase-2 Protects against Lipid Peroxidation-Mediated Cell Loss and Impaired Motor Recovery after Traumatic Brain Injury | Q44747461 | ||
In vivo role of heme oxygenase in ischemic coronary vasodilation | Q44899580 | ||
Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden | Q44907890 | ||
Characterization of cyanobacterial biliverdin reductase. Conversion of biliverdin to bilirubin is important for normal phycobiliprotein biosynthesis | Q46185557 | ||
Effects of age and caloric restriction on lipid peroxidation: measurement of oxidative stress by F2-isoprostane levels | Q46633590 | ||
''Iatrogenic Gilbert syndrome''--a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin | Q47572462 | ||
Heme Oxygenase, a Likely Regulator of cGMP Production in the Brain: Induction in Vivo of HO-1 Compensates for Depression in NO Synthase Activity | Q47818347 | ||
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen | Q48084448 | ||
The oxidoreductase, biliverdin reductase, is induced in human renal carcinoma--pH and cofactor-specific increase in activity | Q48109833 | ||
Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain | Q48270937 | ||
Aging retards spin clearance from mouse brain and food restriction prevents its age-dependent retardation | Q48368333 | ||
The effects of bilirubin on evoked potentials and long-term potentiation in rat hippocampus in vivo | Q48372523 | ||
Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease | Q48833283 | ||
Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease | Q49110302 | ||
[Free radicals, polyunsaturated fatty acids, cell death, brain aging] | Q52254024 | ||
Structure elucidation of oxygenated lipids in human atherosclerotic lesions. | Q53027598 | ||
Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment. | Q53318203 | ||
Defective nuclear translocation of stress-activated signaling in senescent diploid human fibroblasts: a possible explanation for aging-associated apoptosis resistance. | Q53422546 | ||
Senescence-related functional nuclear barrier by down-regulation of nucleo-cytoplasmic trafficking gene expression. | Q53490953 | ||
Age-dependent changes of antioxidant activities and markers of free radical damage in human skeletal muscle. | Q53705528 | ||
Serum Bilirubin and Risk of Respiratory Disease and Death | Q56946006 | ||
Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? | Q35034481 | ||
Diabetes, oxidative stress, and antioxidants: a review | Q35077717 | ||
Oxidative stress, cell cycle, and neurodegeneration | Q35086148 | ||
Senescence of human fibroblasts induced by oncogenic Raf. | Q35210205 | ||
Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study | Q35212898 | ||
Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. | Q35217164 | ||
The iron hypothesis of atherosclerosis and its clinical impact | Q35622037 | ||
Apoptotic cells as sources for biologically active oxidized phospholipids | Q35693462 | ||
Free radicals and brain aging | Q35795706 | ||
Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations | Q35865711 | ||
Heme oxygenase and its products in the nervous system. | Q35877604 | ||
Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts | Q35927191 | ||
Mitochondrial decay in hepatocytes from old rats: membrane potential declines, heterogeneity and oxidants increase | Q36077271 | ||
Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. | Q36267486 | ||
New insights into biliverdin reductase functions: linking heme metabolism to cell signaling | Q36313072 | ||
Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia | Q36380297 | ||
Heme oxygenase-2 is neuroprotective in cerebral ischemia. | Q36438528 | ||
Bilirubin toxicity to human erythrocytes: a review | Q36556015 | ||
Cellular senescence and cancer treatment. | Q36616891 | ||
Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling | Q36657552 | ||
Alzheimer disease, the two-hit hypothesis: an update | Q36671778 | ||
Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment | Q36874545 | ||
Role of Lipids in Brain Injury and Diseases | Q37051065 | ||
Oxidative and inflammatory pathways in Parkinson's disease | Q37117681 | ||
Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury | Q37187635 | ||
Phospholipase A(2), reactive oxygen species, and lipid peroxidation in CNS pathologies | Q37255394 | ||
Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions | Q37314655 | ||
Cell surface biliverdin reductase mediates biliverdin-induced anti-inflammatory effects via phosphatidylinositol 3-kinase and Akt. | Q37372039 | ||
Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities | Q37558528 | ||
Potential application of biliverdin reductase and its fragments to modulate insulin/IGF-1/MAPK/PI3-K signaling pathways in therapeutic settings | Q37779560 | ||
Nuclear barrier hypothesis of aging as mechanism for trade-off growth to survival | Q37929034 | ||
Heme oxygenase-1 and heme oxygenase-2 have distinct roles in the proliferation and survival of olfactory receptor neurons mediated by cGMP and bilirubin, respectively. | Q38520377 | ||
A free radical-generating system regulates APP metabolism/processing. | Q39641426 | ||
Reduction of Nup107 attenuates the growth factor signaling in the senescent cells | Q39656928 | ||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 45 | |
P577 | publication date | 2012-03-14 | |
P1433 | published in | Frontiers in Pharmacology | Q2681208 |
P1476 | title | Physiological antioxidative network of the bilirubin system in aging and age-related diseases | |
P478 | volume | 3 |
Q64095634 | Anti-Wrinkling and Anti-Melanogenic Effect of Methanol Extract |
Q53635920 | Bilirubin provides perforator flap protection from ischaemia-reperfusion injury in a rat model: a preliminary result. |
Q38809993 | Chemical and Physical Approaches to Extend the Replicative and Differentiation Potential of Stem Cells |
Q34014666 | Interleukin-18 alters protein expressions of neurodegenerative diseases-linked proteins in human SH-SY5Y neuron-like cells |
Q38232804 | Senescence suppressors: their practical importance in replicative lifespan extension in stem cells |
Q27023252 | Targeting the redox balance in inflammatory skin conditions |
Q33737263 | The Role of Interleukin-18, Oxidative Stress and Metabolic Syndrome in Alzheimer's Disease |
Q42235267 | The role of bile pigments in health and disease: effects on cell signaling, cytotoxicity, and cytoprotection |
Search more.